Advertisement
Screener

AIM IMMUNOTECH INC. (AIM) Unrealized Gain (Loss) on Investments

1.5 / 5 stars · 24/82 Roast Me

AIM IMMUNOTECH INC. Unrealized Gain (Loss) on Investments

AIM IMMUNOTECH INC. (AIM) reported Unrealized Gain (Loss) on Investments of -$215.00 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-16.

Discontinued › Cash Flow › Operating Activities

us-gaap:UnrealizedGainLossOnInvestments · last filed 2015-11-16

  • AIM IMMUNOTECH INC. unrealized gain (loss) on investments for the quarter ending 2015-09-30 was -$215.00K.
  • AIM IMMUNOTECH INC. unrealized gain (loss) on investments for the quarter ending 2015-06-30 was -$137.00K, a 193.20% decline year-over-year.
  • AIM IMMUNOTECH INC. unrealized gain (loss) on investments for the quarter ending 2015-03-31 was $111.00K, a 428.57% increase year-over-year.
  • AIM IMMUNOTECH INC. unrealized gain (loss) on investments for the quarter ending 2014-12-31 was -$191.00K.
  • AIM IMMUNOTECH INC. unrealized gain (loss) on investments for fiscal 2014 was -$191.00K.
  • AIM IMMUNOTECH INC. unrealized gain (loss) on investments for fiscal 2013 was -$871.00K, a 363.14% decline from fiscal 2012.
  • AIM IMMUNOTECH INC. unrealized gain (loss) on investments for fiscal 2012 was $331.00K.
  • AIM IMMUNOTECH INC. unrealized gain (loss) on investments for fiscal 2011 was -$311.00K.
Period endUnrealized Gain (Loss) on Investments 3 monthUnrealized Gain (Loss) on Investments 3 month as first filedUnrealized Gain (Loss) on Investments 6 monthUnrealized Gain (Loss) on Investments 9 monthUnrealized Gain (Loss) on Investments 9 month as first filedUnrealized Gain (Loss) on Investments 12 monthUnrealized Gain (Loss) on Investments 12 month as first filed
2015-09-30-$215.00K
10-Q · filed 2015-11-16
-$352.00K
derived: sum of 2 quarters · filed 2015-11-16
-$241.00K
10-Q · filed 2015-11-16
-$432.00K
derived: sum of 4 quarters · filed 2015-11-16
2015-06-30-$137.00K
10-Q · filed 2015-08-12
-$26.00K
10-Q · filed 2015-08-12
-$217.00K
derived: sum of 3 quarters · filed 2015-08-12
-$386.00K
derived: sum of 4 quarters · filed 2015-11-16
2015-03-31$111.00K
10-Q · filed 2015-05-12
-$80.00K
derived: sum of 2 quarters · filed 2015-05-12
-$249.00K
derived: sum of 3 quarters · filed 2015-11-16
-$102.00K
derived: sum of 4 quarters · filed 2015-11-16
2014-12-31-$191.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19
-$360.00K
derived: sum of 2 quarters · filed 2015-11-16
-$213.00K
derived: sum of 3 quarters · filed 2015-11-16
-$191.00K
10-K · filed 2015-03-19
2014-09-30-$169.00K
10-Q · filed 2015-11-16
-$22.00K
derived: sum of 2 quarters · filed 2015-11-16
$0.00
10-Q · filed 2015-11-16
-$779.00K
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30$147.00K
10-Q · filed 2015-08-12
$168.00K
10-Q · filed 2015-08-12
-$610.00K
derived: sum of 3 quarters · filed 2015-08-12
$257.00K
derived: sum of 4 quarters · filed 2015-08-12
2014-03-31$21.00K
10-Q · filed 2015-05-12
-$757.00K
derived: sum of 2 quarters · filed 2015-05-12
$110.00K
derived: sum of 3 quarters · filed 2015-05-12
-$895.00K
derived: sum of 4 quarters · filed 2015-05-12
2013-12-31-$778.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19
$89.00K
derived: sum of 2 quarters · filed 2015-03-19
-$916.00K
derived: sum of 3 quarters · filed 2015-03-19
-$871.00K
10-K · filed 2015-03-19
2013-09-30$867.00K
10-Q · filed 2013-11-08
-$138.00K
derived: sum of 2 quarters · filed 2014-08-08
-$93.00K
10-Q · filed 2013-11-08
-$652.00K
derived: sum of 4 quarters · filed 2015-03-19
2013-06-30-$1.00M
10-Q · filed 2014-08-08
-$960.00K
10-Q · filed 2014-08-08
-$1.52M
derived: sum of 3 quarters · filed 2015-03-19
-$1.21M
derived: sum of 4 quarters · filed 2015-03-19
2013-03-31$45.00K
10-Q · filed 2014-05-09
-$514.00K
derived: sum of 2 quarters · filed 2015-03-19
-$208.00K
derived: sum of 3 quarters · filed 2015-03-19
-$21.00K
derived: sum of 4 quarters · filed 2015-03-19
2012-12-31-$559.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19
-$253.00K
derived: sum of 2 quarters · filed 2015-03-19
-$66.00K
derived: sum of 3 quarters · filed 2015-03-19
$331.00K
10-K · filed 2015-03-19
$340.00K
10-K · filed 2013-03-18
2012-09-30$306.00K
10-Q · filed 2013-11-08
$493.00K
derived: sum of 2 quarters · filed 2013-11-08
$890.00K
10-Q · filed 2013-11-08
$981.00K
derived: sum of 4 quarters · filed 2014-03-14
2012-06-30$187.00K
10-Q · filed 2013-08-09
$584.00K
10-Q · filed 2013-08-09
$675.00K
derived: sum of 3 quarters · filed 2014-03-14
$132.00K
derived: sum of 4 quarters · filed 2014-03-14
2012-03-31$397.00K
10-Q · filed 2013-05-08
$488.00K
derived: sum of 2 quarters · filed 2014-03-14
-$55.00K
derived: sum of 3 quarters · filed 2014-03-14
-$209.00K
derived: sum of 4 quarters · filed 2014-03-14
2011-12-31$91.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14
-$452.00K
derived: sum of 2 quarters · filed 2014-03-14
-$606.00K
derived: sum of 3 quarters · filed 2014-03-14
-$311.00K
10-K · filed 2014-03-14
2011-09-30-$543.00K
10-Q · filed 2012-11-02
-$529.00K
10-Q · filed 2011-11-09
-$697.00K
derived: sum of 2 quarters · filed 2012-11-02
-$402.00K
10-Q · filed 2012-11-02
$107.00K
10-Q · filed 2011-11-09
-$1.98M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30-$154.00K
10-Q · filed 2012-08-08
-$141.00K
10-Q · filed 2012-08-08
-$1.44M
derived: sum of 3 quarters · filed 2013-03-18
-$719.00K
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$446.00K
10-Q · filed 2012-05-07
-$1.28M
derived: sum of 2 quarters · filed 2013-03-18
-$565.00K
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31-$1.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
-$1.01M
derived: sum of 2 quarters · filed 2013-03-18
-$1.01M
10-K · filed 2013-03-18
2010-09-30$719.00K
10-Q · filed 2011-11-09
$717.00K
10-Q · filed 2011-11-09
2009-12-31$0.00
10-K · filed 2012-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B